Liang Yu
- Physiology top 5%
- Cancer Research top 10%
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 3
-
- Extracellular vesicles in disease 9
- RNA modifications and cancer 4
- Circular RNAs in diseases 4
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 3
-
- Ferroptosis and cancer prognosis 7
Liang Yu
32 papers receiving 837 citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Physiology 85
- Cancer Research 185
- Molecular Biology 597
- Cell Biology 91
- Aging 9
Countries citing papers authored by Liang Yu
This map shows the geographic impact of Liang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Yu more than expected).
Fields of papers citing papers by Liang Yu
This network shows the impact of papers produced by Liang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Yu. The network helps show where Liang Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liang Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 4 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 20 | |
| 16 | 2019 | 11 | |
| 17 | 2017 | 66 | |
| 18 | 2016 | 22 | |
| 19 | 2014 | 4 | |
| 20 | 2014 | 23 |
About Liang Yu
Liang Yu is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 839 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Extracellular vesicles in disease (9 papers), Ferroptosis and cancer prognosis (7 papers), RNA modifications and cancer (4 papers), Circular RNAs in diseases (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Physiology (85 citations), Cancer Research (185 citations) and Molecular Biology (597 citations). Liang Yu has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Jiahuai Han, Mengqi Li, Terytty Yang Li, Zhiyun Ye, Yalin Zhang, Jiawei Wu, Mingjiang Zhu, Chen‐Song Zhang, Bin Jiang and Huiyong Yin. Their work appears in journals such as Frontiers in Immunology, Hepatology International, Frontiers in Pharmacology, Molecular Cancer Therapeutics and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.